Skip to main content
SpringerLink
Log in

Proliferation markers in the study of endocrine diseases

  • Editorial
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bravo R, Macdonald Bravo H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 105:1549, 1987.

    Article  PubMed  CAS  Google Scholar 

  2. Waseem NH, Lane DP. Monoclonal antibody analysis of the proliferating cell nuclear antigen structural conservation and the detection of a nucleolar form. J Cell Sci 96:121, 1990.

    PubMed  CAS  Google Scholar 

  3. Gerdes J. Ki-67 and other proliferation markers useful for immunohistologic diagnostic and prognostic evaluations in human malignancies. In: Osborn M, ed. Seminars in cancer biology. London: Saunders Scientific Publications, 1990; 99.

    Google Scholar 

  4. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13, 1983.

    Article  PubMed  CAS  Google Scholar 

  5. Gerdes J, Becker MH, Key G. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 168:85, 1992.

    Article  PubMed  CAS  Google Scholar 

  6. Kamel OW, LeBrun DP, Davis RE, Berry GJ, Warnke RA. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin embedded tissues using anti-PCNA/cyclin 19A2. Correlation with Ki-67 labeling. Am J Pathol 138:1471, 1991.

    PubMed  CAS  Google Scholar 

  7. Yu CC, Fletcher CEM, Newman PL, Goodlad JR, Burton JC, Levison DA. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours. J Pathol 166:147, 1992.

    Article  PubMed  CAS  Google Scholar 

  8. Yu CC, Hall PA, Fletcher CDM, Camplejohns RS, Waseem NH, Lane DP, Levison DA. Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA). Histopathology 19:29, 1991.

    Article  PubMed  CAS  Google Scholar 

  9. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17:489, 1990.

    Article  PubMed  CAS  Google Scholar 

  10. Suzuki T, Sasano H, Nisikawa T, Rhame J, Wilkinson DS, Nagura H. Discerning malignancy in human adrenocortical neoplasms: utility of DNA flow cytometry and immuno-histochemistry. Mod Pathol 5:224, 1992.

    PubMed  CAS  Google Scholar 

  11. Goldblum JR, Shannon R, Kaldjian EP, Thiny M, Davenport R, Thompson N, Lloyd RV. Immunohistochemical assessment of proliferative activity in adenocritical neoplasms. Mod Pathol 6:663, 1993.

    PubMed  CAS  Google Scholar 

  12. Carr K, Heffess C, Lin L, Lloyd RV. Immuno-histochemical analysis of thyroid carcinomas utilizing antibodies to p53 and Ki-67. Appl Immunohistochem 1:201–207, 1993.

    Google Scholar 

  13. Tateyama H, Yang Y-P, Eimoto T, Tada T, Inagaki H, Nakamura T, Iwase H, Kobayashi S. Proliferative cell nuclear antigen expression in follicular tumours of the thyroid with special reference to oxyphilic cell lesions. Virchow Arch 424:533–537, 1994.

    CAS  Google Scholar 

  14. Pelosi G, Zamboni G, Dogliomi C, Rodella S, Bresaola E, Iacono C, Serio G, Iannucci A, Scarpia A. Immunodetection of proliferating cell nuclear antigen assesses the growth fraction and predicts malignancy in endocrine tumors of the pancreas. Am J Surg Pathol 16:1215–1225, 1992.

    Article  PubMed  CAS  Google Scholar 

  15. Papotti M, Abbona GC, Gasparn G, Ardeleanu C, Bussoloti G. Proliferative activity of hyperplastic and neoplastic lesions of the parathyroid gland as detected by Ki-67 immunohistochemistry. Lab Invest 70:55A, 1994.

    Google Scholar 

  16. Loda M, Lipman J, Cukor B, Bur M, Kwan P, DeLellis RA. Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity. Hum Pathol 25:1050–1056, 1994.

    Article  PubMed  CAS  Google Scholar 

  17. Kramer A, Saeger W, Tallen G, Ludecke DK. DNA measurement, proliferation markers and other factors in pituitary adenomas. Endocr Pathol 5:198–211, 1994.

    Google Scholar 

  18. Hsu DW, Hakin F, Biller BMK, Dela Monte S, Zervas N, Klibanski A, Hedley-Whyte E. Significance of proliferating cell nuclear antigens index in predicting pituitary adenoma recurrence. J Neurosurg 78:753–761, 1993.

    Article  PubMed  CAS  Google Scholar 

  19. Landol AM, Shibata T, Kleihues P. Growth rate of human pituitary adenomas. J. Neurosurg 67:803, 1989.

    Google Scholar 

  20. Kimura N, Miura W, Noshiru T, Miura Y, Ookuma T, Nagura H. Ki-67 is an indicator of progression of neuroendocrine tumor. Endocr Pathol 5:223–228, 1994.

    Article  Google Scholar 

  21. Kelleher L, Magee HM, Dervan PA. Evaluation of cell-proliferation antibodies reactive in paraffin sections. Applied Immunohistochem 2:164–170, 1994.

    Google Scholar 

  22. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J. Monoclonal antibody against recurrent parts of the Ki-67 antigen (MIB I and MIB 3) detect proliferating cells in immune-processed formalin-fixed paraffin sections. J Pathol 168:357–363, 1992.

    Article  PubMed  CAS  Google Scholar 

  23. Becksteadl JH. Improved antigen retrieval in formalin-fixed, paraffin embedded tissues. Appl Immunohistochem 2:274–281, 1994.

    Google Scholar 

  24. Sebo TJ. Digital image analysis. Mayo Clinic Proceed 70:81, 82. 1995.

    CAS  Google Scholar 

  25. Sherr CJ. G1 phase progression: cycling on cue. Cell 79:551–555, 1994.

    Article  PubMed  CAS  Google Scholar 

  26. Hunter T, and Pines J. Cyclins and cancer II: cyclin D and inhibitors came of age. Cell 79:573–582, 1994.

    Article  PubMed  CAS  Google Scholar 

  27. King RW, Jackson PK, Kirschner MW. Mitosis in transition. Cell 79:563–571, 1994.

    Article  PubMed  CAS  Google Scholar 

  28. Hinds PW, Dowdy SF, Eaton EN, Aronold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91:709–713, 1994.

    Article  PubMed  CAS  Google Scholar 

  29. Polyak K, Kato J-Y, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A. p27KIP, a cyclin-cdk inhibitor links transforming growth factor-B and contact inhibition to cell cycle arrest. Genes Dev 8:9–22, 1994.

    Article  PubMed  CAS  Google Scholar 

  30. Hannon FJ, Beach D. P15InK4B is a potential effector of TGF-B-induced cell arrest. Nature 371:257–261, 1994.

    Article  PubMed  CAS  Google Scholar 

  31. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 266:1821–1828, 1994.

    Article  PubMed  CAS  Google Scholar 

  32. Bodey B, Williams RT, Carbonaro-Hall DA, Horvath A, Tolu VT, Luck J Jr, Taylor CR, Hall FL. Immunocytochemical detection of cyclin A and cyclin D in formalin-fixed, paraffin-embedded tissues: novel, pertinent markers of cell proliferation. Mod Pathol 7:846–852, 1994.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, 55905, Rochester, MN

    Ricardo V. Lloyd MD, PhD

Authors
  1. Ricardo V. Lloyd MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lloyd, R.V. Proliferation markers in the study of endocrine diseases. Endocr Pathol 6, 83–86 (1995). https://doi.org/10.1007/BF02739870

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02739870

Search

Navigation